Skip to main content
. 2022 May 9;14(9):2335. doi: 10.3390/cancers14092335

Figure 2.

Figure 2

(A). Disease-free survival (DFS) in HPV-, HPV+, and all patients according to body mass index (BMI), total lymphocyte count (TLC), hemoglobin (HB) level, and C-reactive protein (CRP) level. (B). Disease-free survival (DFS) in HPV-, HPV+, and all patients according to albumin and prealbumin levels and prognostic nutritional index (PNI).